Literature DB >> 6020292

Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.

J E Seegmiller, F M Rosenbloom, W N Kelley.   

Abstract

A sex-linked familial neurological disease consisting of cerebral palsy, mental retardation, choreoathetosis, and compulsive aggressive behavior is associated with a loss of an enzyme that participates in purine metabolism, namely, hypoxanthine-guanine phosphoribosyltransferase. The production of excessive uric acid in this disorder implies that the enzyme is involved in the normal regulation of purine biosynthesis. This is the first example of a relation between a specific enzyme defect and abnormal compulsive behavior. It is also the first enzyme defect in purine metabolism demonstrated in a neurological disease.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6020292     DOI: 10.1126/science.155.3770.1682

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  232 in total

1.  Gene correction in hematopoietic progenitor cells by homologous recombination.

Authors:  S Hatada; K Nikkuni; S A Bentley; S Kirby; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  A deficiency in nucleoside salvage impairs murine lymphocyte development, homeostasis, and survival.

Authors:  Onjee Choi; Dean A Heathcote; Ka-Kei Ho; Phillip J Müller; Hazim Ghani; Eric W-F Lam; Philip G Ashton-Rickardt; Sophie Rutschmann
Journal:  J Immunol       Date:  2012-03-09       Impact factor: 5.422

3.  Adenosine, dopamine and serotonin receptors imbalance in lymphocytes of Lesch-Nyhan patients.

Authors:  Marta G García; Juan G Puig; Rosa J Torres
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

4.  Relation between creatinine and uric acid excretion.

Authors:  Y Nishida
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

5.  Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.

Authors:  R W Watts; Y S Perera; J Allsop; C Newton; T A Platts-Mills; A D Webster
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

6.  Developmental changes in purine phosphoribosyltransferases in human and rat tissues.

Authors:  A Adams; R A Harkness
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

7.  Cypin: A novel target for traumatic brain injury.

Authors:  Przemyslaw Swiatkowski; Emily Sewell; Eric S Sweet; Samantha Dickson; Rachel A Swanson; Sara A McEwan; Nicholas Cuccolo; Mark E McDonnell; Mihir V Patel; Nevin Varghese; Barclay Morrison; Allen B Reitz; David F Meaney; Bonnie L Firestein
Journal:  Neurobiol Dis       Date:  2018-07-19       Impact factor: 5.996

Review 8.  Urolithiasis in children: current medical management.

Authors:  J Laufer; H Boichis
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

9.  Activation of variants of hypoxanthine-guanine phosphoribosyl transferase by the normal enzyme.

Authors:  B Bakay; W L Nyhan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

10.  Hypoxanthine-guanine phosphoribosyltransferase deficiency in three brothers with gout: characterization of a variant, HPRTEdinburgh, having altered isoelectric point, increased thermal lability and normal levels of messenger RNA.

Authors:  F F Snyder; J E Joyce; T Carter-Edwards; R Joshi; H L Rylance; R C Wallace; G Nuki
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.